Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1981-7-20
|
pubmed:abstractText |
Scopolamine reversed the reduction in avoidance responding caused by spiperone and antagonized the inhibitory effects of spiperone on the behavioral actions of d-amphetamine or apomorphine. Scopolamine-induced locomotor activity was greater in 6-hydroxydopamine (6-OHDA)-treated animals than in controls. This increase was prevented by administration of alpha-methyltyrosine, but not by inhibition of dopamine-beta-hydroxylase, indicating that this action of scopolamine was associated with presynaptic dopaminergic fibers. Therefore, the possibility that pre-synaptic dopaminergic function was the locus of the antagonism of spiperone by scopolamine was examined using drug interaction studies in 6-OHDA-treated rats. However, when 6-OHDA-treated rats were given alpha-methyltyrosine, scopolamine still reversed the spiperone blockade of apomorphine-induced locomotion. Although these data provided evidence for a post-synaptic action for this cholinergic blocking agent, scopolamine affected neither dopamine-stimulated adenylate cyclase activity nor 3H-spiperone binding in vitro. Furthermore, scopolamine did not alter the level of specific 3H-spiperone binding found in brain after in vivo administration. This suggests that the post-synaptic mechanism affected by scopolamine is different from the site affected by spiperone. Thus, it is concluded that scopolamine can affect both pre- or post-synaptic events associated with dopaminergic function and that both may contribute to the reversal of the actions of spiperone.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0033-3158
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
17-22
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6112768-Adenylate Cyclase,
pubmed-meshheading:6112768-Animals,
pubmed-meshheading:6112768-Antipsychotic Agents,
pubmed-meshheading:6112768-Avoidance Learning,
pubmed-meshheading:6112768-Behavior, Animal,
pubmed-meshheading:6112768-Brain Chemistry,
pubmed-meshheading:6112768-Humans,
pubmed-meshheading:6112768-Male,
pubmed-meshheading:6112768-Motor Activity,
pubmed-meshheading:6112768-Rats,
pubmed-meshheading:6112768-Receptors, Dopamine,
pubmed-meshheading:6112768-Scopolamine Hydrobromide,
pubmed-meshheading:6112768-Stereotyped Behavior,
pubmed-meshheading:6112768-Synapses
|
pubmed:year |
1981
|
pubmed:articleTitle |
Behavioral and biochemical studies of the scopolamine-induced reversal of neuroleptic activity.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|